Royalty Pharma to report third-quarter 2026 results on Nov. 4, 2026
Royalty Pharma (RPRX) said it will announce third-quarter 2026 financial results on November 4, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bitcoin falls 2.3% as Treasury yields rise
Bitcoin traded near $83,559, down 2.3% on the day, as markets reacted to rising Treasury yields and a hawkish shift in the Fed backdrop.
Bitcoin hovers near $83,500 as stocks trim losses
Bitcoin sold off and hovered near $83,500 while U.S. stock indexes pared earlier declines after Treasury yields and oil pulled back. The move came during broader afternoon trading that also saw the Dow, S&P 500 and Nasdaq recover some ground.
REG — BioPharma Credit PLC — Half — year Financial Report
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv
Transcript: Aytu BioPharma Q4 2026 Earnings Conference Call
On Tuesday, Aytu BioPharma (NASDAQ: AYTU ) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Aytu BioPharma reported